Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...

Australian researchers are about to launch a human trial to treat spinal cord injury by transplanting cells from the noses of paralysed patients into the damaged area. Griffith University ...

After a spinal cord injury, nearby cells quickly rush to action, forming protective scar tissue around the damaged area to stabilize and protect it. But over time, too much scarring can prevent ...

A key to their investigation was to elucidate the critical involvement of microglia in axonal degeneration post-spinal cord axon injury. Microglia are primary immune cells in the central nervous ...

“Our innovative nerve bridges, combined with the high purity olfactory cells, offer what we think is the best hope for treating spinal cord injury,” Professor James St John of Griffith ...

People who experience spinal ... the injury. Complete recovery is especially difficult in severe cases, and the prohibitive costs and limited availability of advanced treatments like stem cell ...

Don't miss out on the headlines from Lifestyle. Followed categories will be added to My News. The trial, which will begin in early 2025, will test the efficacy and safety of the groundbreaking ...

Near-infrared therapy is emerging as a promising treatment for brain injuries, offering new hope for recovery by enhancing ...

NASS’s 2024 Research Funding Program announced grants and traveling fellowships winners totaling $159,059 this year.